Checkpoint Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Checkpoint Therapeutics, Inc.‘s stocks are currently a part of 17 hedge funds’ portfolios, which represents 5.62% of the total amount of its stocks outstanding. This makes up a total of 496.35K shares of Checkpoint Therapeutics, Inc.. Compared to the previous quarter, the number fell by -73.93% or -1.40M shares fewer. As for the holding position changes, 47.06% (8) of current hedge fund investors increased the number of shares held, 11.76% (2) of current holders sold a part of the shares held, and 29.41% (5) closed the holdings completely. 5 hedge funds are new holders of Checkpoint Therapeutics, Inc. stock in Q1 2023, it is 29.41% of total holders.
Hedge funds holding Checkpoint Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 10 |
|---|---|
| Q3 2018 | 15 |
| Q4 2018 | 19 |
| Q1 2019 | 22 |
| Q2 2019 | 40 |
| Q3 2019 | 37 |
| Q4 2019 | 35 |
| Q1 2020 | 41 |
| Q2 2020 | 45 |
| Q3 2020 | 53 |
| Q4 2020 | 62 |
| Q1 2021 | 70 |
| Q2 2021 | 68 |
| Q3 2021 | 64 |
| Q4 2021 | 61 |
| Q1 2022 | 64 |
| Q2 2022 | 57 |
| Q3 2022 | 54 |
| Q4 2022 | 38 |
| Q1 2023 | 17 |
Hedge funds changes in Checkpoint Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 4 | 3 | 1 | 5 | -3 |
|---|---|---|---|---|---|
| Q3 2018 | 7 | 3 | 3 | 2 | 0 |
| Q4 2018 | 5 | 6 | 4 | 1 | 3 |
| Q1 2019 | 6 | 6 | 4 | 3 | 3 |
| Q2 2019 | 24 | 10 | 5 | 6 | -5 |
| Q3 2019 | 5 | 15 | 9 | 8 | 0 |
| Q4 2019 | 5 | 14 | 7 | 5 | 4 |
| Q1 2020 | 9 | 16 | 7 | 3 | 6 |
| Q2 2020 | 9 | 20 | 6 | 5 | 5 |
| Q3 2020 | 11 | 19 | 11 | 3 | 9 |
| Q4 2020 | 17 | 29 | 8 | 8 | 0 |
| Q1 2021 | 16 | 27 | 17 | 8 | 2 |
| Q2 2021 | 19 | 17 | 19 | 20 | -7 |
| Q3 2021 | 13 | 21 | 15 | 17 | -2 |
| Q4 2021 | 12 | 14 | 14 | 13 | 8 |
| Q1 2022 | 16 | 19 | 14 | 11 | 4 |
| Q2 2022 | 8 | 11 | 16 | 12 | 10 |
| Q3 2022 | 3 | 13 | 13 | 7 | 18 |
| Q4 2022 | 38 | 0 | 0 | 52 | -52 |
| Q1 2023 | 5 | 8 | 2 | 5 | -3 |
Hedge funds changes in Checkpoint Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 4,000 | 1,000 |
| Q2 2021 | 819,000 | 647,000 |
| Q3 2021 | 1,097,000 | 498,000 |
| Q4 2021 | 782,000 | 304,000 |
| Q1 2022 | 489,000 | 379,000 |
| Q2 2022 | 480,000 | 137,000 |
| Q3 2022 | 411,000 | 957,280 |
| Q4 2022 | 391,049 | 51,391 |
| Q1 2023 | 14,688,000 | 10,207,000 |